The Natural History of Danon Disease
Danon disease (DD) is a rare, X-linked disorder associated with severe cardiomyopathy, and in many cases, skeletal myopathy, and cognitive impairment caused by mutations in the LAMP2 gene. There is still uncertainty regarding the natural history of DD because of its rarity.
This study aims to determine the natural history of DD through the collection and analysis of retrospective and prospective data. To achieve this, the investigators will perform surveys and obtain medical records from DD patients. The same cohort of patients will also be assessed by a multidisciplinary team with expertise in DD (cardiologist, neurologist, ophthalmologist, psychologist, geneticist) at the University of California, San Diego. All patients with DD are eligible, including those who underwent a heart transplant. Additionally, data and records from deceased patients will provide valuable retrospective data for this study.
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
The study design will include:
Collection of information for all patients from:
- Survey of patient or caregiver (if the patient has deceased)
- Medical Charts
Collection of information from living patients assessed by the multidisciplinary team at the University of California, San Diego including:
- A complete medical history and physical examination
- Cardiac Testing (Electrocardiography; Echocardiography; Cardiac magnetic resonance imaging with gadolinium contrast agent-gadolinium contrast is optional-; Cardiopulmonary Test)
- Pulmonary function testing (PFT)
- Neuromuscular Assessment
- Cognitive Tests
- Vision exam including retinal evaluation
- Laboratory Tests
- Questionnaires on Quality of life
- Needle Skeletal muscle biopsy (only for patients over 18 years old)
- Abdominal Ultrasound for assessment of the liver structure
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Eric Adler, MD
- Phone Number: 8582462996
- Email: eradler@ucsd.edu
Study Locations
-
-
California
-
San Diego, California, United States, 92122-5671
- Recruiting
- University of California, San Diego
-
Contact:
- Eric Adler, MD
- Email: eradler@ucsd.edu
-
Contact:
- Michela Brambatti, MD,MS
- Email: mbrambatti@ucsd.edu
-
Sub-Investigator:
- Michela Brambatti, MD,MS
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
• Living or deceased patients with a diagnosis of Danon disease(including patients who may or may not have undergone heart transplantation) based on a genetic test positive for the LAMP2 mutation
Exclusion Criteria:
• Patients without a genetic test positive for a LAMP2 mutation
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Danon Disease Patients
Patients with a confirmed diagnosis of Danon disease who are currently alive (including patients who may or may not have undergone heart transplantation).
|
|
Deceased Danon Disease Patients
Patients with a confirmed diagnosis of Danon disease who are deceased (including patients who may or may not have undergone heart transplantation).
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac structure over time
Time Frame: 6, 12, 18, 24, 30, 36 months
|
Change of cardiac structure (wall thickness -mm) measured by cardiac ultrasound / cardiac magnetic resonance
|
6, 12, 18, 24, 30, 36 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Heart Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Genetic Diseases, Inborn
- Genetic Diseases, X-Linked
- Carbohydrate Metabolism, Inborn Errors
- Metabolism, Inborn Errors
- Mental Retardation, X-Linked
- Intellectual Disability
- Cardiomyopathies
- Glycogen Storage Disease
- Glycogen Storage Disease Type IIb
Other Study ID Numbers
Other Study ID Numbers
- 170727
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.